PM360 2018 Innovative Startup H1

H1

Emma Schroeter, Sales Development Representative
emma.schroeter@h1insights.com 

H1 is the first company to arm healthcare organizations with live data insights to help fight diseases. The company provides real-time data from across the data universe to support the end-to-end therapeutic development process from fundraising to product development to product launch, helping healthcare and life sciences companies make smarter scientific decisions. Working with medical affairs and strategy teams who span all phases of the development lifecycle, H1 provides the complete picture of institutions, experts, scholarly content, markets, competitors, and new opportunities through research grounded in actual data and clinical findings.

While there are dozens of open sources for scholarly and clinical data that cover billions of data points such as PubMed, clinical trials, patents, UMLS, proteins, gene ontology, PubChem, conferences, grants, CMS, etc., no company has built the big data pipeline or machine learning algorithms to aggregate and make sense of all this data. H1 is the first company to pull in the majority of these sources, ensure they are kept up to date, and build software products on top of the data to help with drug development.

By harnessing this data, H1 can help companies in several areas such as clinical trials investigator and site analysis, key opinion leader identification, clinical and preclinical protocol analysis, and competitive landscaping. Currently, the company has three product offerings: H1.Ada (which supplies a comprehensive and up-to-date record of people and organizations driving medicine); H1.Curie (which has information and analytics regarding opinion thought leaders); and H1.DaVinci (which provides Strategy as a Service that can help develop strategies within the areas of market landscape, competitive intelligence, and opportunity identification).

Ads

You May Also Like

2017 Pharma Choice Bronze Multichannel

HCB Health Mitsubishi Tanabe Pharma America ALS Pathways ALS has traditionally been an underserved ...

Good Question!

In recent conversations with life science companies about oncology market research, MDoutlook has heard ...

My Other Life with Robert Burke

PM360 recently spoke to Robert Burke, Product Director, XARELTO, Janssen Pharmaceuticals, about preparing for ...